Gastroenterology Insights (Sep 2021)

Anemia in Newly Diagnosed Pediatric Patients with Inflammatory Bowel Disease

  • Rayna Shentova-Eneva,
  • Denitza Kofinova,
  • Petyo Hadzhiyski,
  • Penka Yaneva,
  • Elena Lazarova,
  • Mila Baycheva

DOI
https://doi.org/10.3390/gastroent12040036
Journal volume & issue
Vol. 12, no. 4
pp. 376 – 383

Abstract

Read online

Anemia is the most common extraintestinal manifestation and complication of inflammatory bowel disease (IBD). The aim of our study was to assess the prevalence of anemia in newly diagnosed pediatric patients with IBD and to analyze its association with disease type, extent, and severity. We retrospectively reviewed the medical records of all patients with IBD treated in our department in the period of November 2011 to November 2020. The final analysis included the records of 80 children with newly diagnosed IBD: 45 with ulcerative colitis (UC) and 35 with Crohn’s disease (CD). The prevalence of anemia was 60.0% in the UC patients and 77.1% in the CD patients. Of the UC patients with anemia, 37.1% had pancolitis, 18.5% extensive disease, 33.3% left-sided colitis and 11.1% ulcerative proctitis. Of the CD patients with anemia, 81.5% had ileocolonic disease, 11.1% colonic disease and 7.4% ileal disease. Anemia was less common in patients with mild disease than in patients with moderate–severe disease (22.2 vs. 77.8%, p p < 0.001 in CD). Our study confirmed anemia as a frequent problem in pediatric patients with IBD. Children with more extensive and more severe disease are at higher risk to develop anemia.

Keywords